About: PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) im Februar 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в лютому 2019 (uk)
publication date	wds:Q64236178-536208A3-AA1C-4695-BAB9-6DDD4B88A2AE
publication date	2019-02-15 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64236178-F39A5348-251C-4F2A-B387-9C05A5A173E7
language of work or name	English
cites work	wds:Q64236178-07359B5B-162C-4A2D-AAB3-1E2EEC7B9E32 wds:Q64236178-15B76B67-8CC3-4C8A-AE93-32DF1F77CEF5 wds:Q64236178-1F403E08-9402-4CFF-A586-66328F2F01C3 wds:Q64236178-261B5355-1CA2-4CF7-90ED-9C8A27DB5571 wds:Q64236178-2F5E08EB-D23B-437A-938B-179EB118B972 wds:Q64236178-35961FBD-7645-4BD0-8720-54D4E441503E wds:Q64236178-3D0D613F-E80E-4B83-A30F-A085E0115D06 wds:Q64236178-6906855F-FE02-4C75-903E-110B92B1D6F4 wds:Q64236178-83ADC734-6D95-432A-9F77-68C0493EEBF9 wds:Q64236178-9815F6C3-8BD6-4D5C-ADE5-6333A09DC4DB wds:Q64236178-B222C7C7-77DD-4637-AF34-1B4B042A85CE wds:Q64236178-C0A09544-D269-467C-AAF1-702DEE2E32AC wds:Q64236178-C6A4CEE0-8112-4083-B419-EC7476D86E1F wds:Q64236178-CCD3F9A4-3BA4-4B78-BB79-5DB9FC72099C wds:Q64236178-F055B7B4-EF79-4664-BF99-DAF02A964881 wds:Q64236178-F6F4D8F3-1604-457B-A32E-5D3635B6FFB6
cites work	A model to predict survival in patients with end-stage liver disease The role of intestinal endotoxin in liver injury: a long and evolving history Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. Alterations of the human gut microbiome in liver cirrhosis Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis Bacterial translocation (BT) in cirrhosis Altered profile of human gut microbiome is associated with cirrhosis and its complications Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.
author name string	wds:Q64236178-05816F7C-0BF6-4B39-A72A-C0ED0D2847CF wds:Q64236178-9368CC8C-E400-49CD-A19B-5917D6FB6EAE wds:Q64236178-DE3FDB8A-D552-47F0-B3CE-22D8FD4F589F
author name string	Alastair O'Brien Simon Goldenberg Charlotte Alexandra Woodhouse
rdfs:label	PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (en) PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (nl)
skos:prefLabel	PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (en) PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (nl)
name	PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (en) PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (nl)
author	wds:Q64236178-09478741-A2AB-4D95-82CE-144B69685A88 wds:Q64236178-30C0D22C-93A3-4263-908D-AB7D8D288C9F wds:Q64236178-7D14D321-52D1-4B9C-AABD-E5E72B3F3AB9 wds:Q64236178-8FD66060-3D49-44BB-A85F-F32EAC8580E0 wds:Q64236178-9636E700-8361-48FD-8875-DFC16493179B wds:Q64236178-96993ECA-EE61-4E6D-A764-3286A83544B8
author	Debbie L Shawcross Clare Flach Abdel Douiri Vishal C. Patel Alberto Sanchez-Fueyo Louise China
title	wds:Q64236178-02984935-E8A1-4DE4-9D61-1799C6513DC1
title	PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial (en)
page(s)	wds:Q64236178-4E6D338C-3583-46AF-B437-E5F8E3AAC47D
page(s)	e023518
instance of	wds:Q64236178-3C1CA75A-8AA7-40D6-96E9-0F4D1C5D0477
instance of	scholarly article
main subject	wds:Q64236178-1201BEE4-51AF-4543-87B5-B86E81BF0108 wds:Q64236178-58CEB2BD-754E-4C63-96E9-C12316482DBC wds:Q64236178-8ED1C01C-A963-41C1-93E8-45224B377976 wds:Q64236178-9CA2D7C6-169A-4B63-BF93-468778957C23 wds:Q64236178-D1720564-AA50-40DC-94C4-E22348CB1C59
main subject	feces placebo liver cirrhosis study protocol Feasibility
PubMed ID	wds:Q64236178-1E53A888-D466-47DB-8F22-20471C7F5EDE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30772848
PubMed ID	30772848
published in	wds:Q64236178-A34CFBF6-19EC-4648-8A75-8AFE4A789E66
published in	BMJ Open
issue	wds:Q64236178-85F994B3-B3CA-4758-8CD7-02CB05D3AA0F
volume	wds:Q64236178-EF22465C-90C3-40CC-83A5-A066481172F9
issue	2
volume	9
DOI	wds:Q64236178-4D899E56-F720-4FBC-B44C-4EFA1E15D647
DOI	http://dx.doi.org/10.1136/BMJOPEN-2018-023518
DOI	10.1136/BMJOPEN-2018-023518
PMCID	wds:Q64236178-E23C9046-6220-47C4-A3C4-599317D18636
PMCID	6398649
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64236178
is cites work of	Antimicrobial resistance in chronic liver disease The use of fecal microbiota transplant in sepsis Role of Microbiota in Pathogenesis and Management of Viral Hepatitis
is cites work of	wds:Q91661264-D9586203-4553-4C94-8B28-B332EC08AE43

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software